 |
|
Anemia With Impaired Erythropoietin Response in Diabetic Patients
Merlin C. Thomas, MBChB, PhD;
Mark E. Cooper, MBBS, PhD;
Con Tsalamandris, MBBS;
Richard MacIsaac, MBBS, PhD;
George Jerums, MBBS, MD
Arch Intern Med. 2005;165:466-469.
Background Diabetes mellitus is associated with an increased prevalence of anemia, particularly in patients with nephropathy. We undertook this survey to determine the relationship between anemia and the renal production of erythropoietin in patients with diabetes mellitus.
Methods The clinical data of 722 patients were obtained, including markers of diabetic complications. Erythropoietin levels were measured in the same samples. Patients with a full blood cell count, iron indexes, and renal function within the normal range (n = 151) were used to define the reference range for this population. Anemic patients who had erythropoietin levels within this range were defined as having an "inappropriate erythropoietin response to anemia."
Results Of the 722 patients, 168 (23.3%) had anemia, of whom 130 (77.4%) had erythropoietin levels inappropriately within the normal range. Although 55.4% of anemic patients had moderate renal impairment, erythropoietin levels were also inappropriately low in 69.2% of anemic patients with normal renal function. However, most of these patients (17 of 26) had diabetic kidney disease, as denoted by albuminuria.
Conclusions The failure to produce erythropoietin in response to a declining hemoglobin level is a common contributor to anemia in patients with diabetes mellitus. This seems to be a manifestation of diabetic kidney disease, in the presence or absence of renal impairment.
Author Affiliations: Danielle Alberti Memorial Centre for Diabetes Complications, Baker Medical Research Institute, Melbourne (Drs Thomas and Cooper), and Department of Endocrinology, Austin and Repatriation Medical Centre, Heidelberg (Drs Tsalamandris, MacIsaac, and Jerums), Victoria, Australia.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Racial variation in the relationship of anemia with mortality and mobility disability among older adults
Patel et al.
Blood 2007;109:4663-4670.
ABSTRACT
| FULL TEXT
Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients
Rossert et al.
Nephrol Dial Transplant 2007;22:794-800.
ABSTRACT
| FULL TEXT
Abnormal haemoglobin levels in acute coronary syndromes.
Bindra et al.
QJM 2006;99:851-862.
ABSTRACT
| FULL TEXT
Clinical Correlates and Consequences of Anemia in a Broad Spectrum of Patients With Heart Failure: Results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program
O'Meara et al.
Circulation 2006;113:986-994.
ABSTRACT
| FULL TEXT
Anemia in the Elderly: Time for New Blood in Old Vessels?
Spivak
Arch Intern Med 2005;165:2187-2189.
FULL TEXT
|
